The deal is Eli Lilly’s latest attempt to capitalize on the weight loss industry gold rush, which was sparked by demand for Novo Nordisk’s Wegovy and Ozempic.
You are here: Home / Obesity drug maker Versanis to be bought by Eli Lilly for $1.9 billion